Key facts
- This page summarizes James William Burns's Form 3 filing for AGIOS PHARMACEUTICALS, INC. (AGIO).
- 0 reported transactions and 11 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2022, 15:07.
James William Burns - 01 Jan 2022 Form 3 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- AGIO
- Reported as of
- 01 Jan 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Jan 2022, 15:07:18 UTC
- Next SEC filing
- 14 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Cook, as Attorney in Fact for James Burns
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
James William Burns filed Form 3 for AGIOS PHARMACEUTICALS, INC. (AGIO) on 10 Jan 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGIO
holding
Common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,261
- Date
- 01 Jan 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGIO
holding
Derivative
Restricted stock units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 724
- Exercise price
- Footnotes
- F1, F2
AGIO
holding
Derivative
Restricted stock units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 5,250
- Exercise price
- Footnotes
- F2, F3
AGIO
holding
Derivative
Restricted stock units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 3,476
- Exercise price
- Footnotes
- F2, F4
AGIO
holding
Derivative
Restricted stock units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 8,750
- Exercise price
- Footnotes
- F2, F5
AGIO
holding
Derivative
Restricted stock units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 5,500
- Exercise price
- Footnotes
- F2, F6
AGIO
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 5,420
- Exercise price
- $43.77
- Footnotes
- F7
AGIO
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 5,749
- Exercise price
- $50.40
- Footnotes
- F8
AGIO
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 8,295
- Exercise price
- $77.70
- Footnotes
- F9
AGIO
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 8,690
- Exercise price
- $58.86
- Footnotes
- F10
AGIO
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 2,607
- Exercise price
- $51.51
- Footnotes
- F11
AGIO
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 22,000
- Exercise price
- $56.68
- Footnotes
- F12
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 12 footnotes
Footnote F1
The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F3
The restricted stock units were granted on February 14, 2020. The shares underlying the restricted stock units will vest in full on February 14, 2022.
Footnote F4
The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
Footnote F5
The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.
Footnote F6
The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
Footnote F7
This option was granted on April 4, 2016. The shares underlying this option are fully vested.
Footnote F8
This option was granted on February 21, 2017. The shares underlying this option are fully vested.
Footnote F9
This option was granted on February 16, 2018. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Footnote F10
This option was granted on February 22, 2019. The shares underlying this option vest as to 25% of the underlying shares on February 22, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Footnote F11
This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Footnote F12
This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.